Ifetroban in Treating Patients With Malignant Solid Tumors at High Risk of Metastatic Recurrence
Status:
Recruiting
Trial end date:
2025-01-01
Target enrollment:
Participant gender:
Summary
This pilot trial studies the side effects of ifetroban in treating patients with malignant
solid tumors that are at high risk of coming back after treatment and spreading throughout
the body. Platelets are a type of blood cells that help with clotting. Cancer cells stick to
platelets and ride on them to get to different parts of the body. Drugs, such as ifetroban,
may help these platelets become less "sticky," and reduce the chance of cancer cells
spreading to other places in the body.